ACE inhibitors on heavy market competition.

The market share of ACE (Angiotensin II) inhibitor drugs showed about 10% last year out of the total 320 billion won of anti-hypertensive drug markets (including diuretics), and estimated to run up to 20to 30% this year.

MSD's Cozaar (Losartan) was introduced in Korea in Sept. 1997 and registered in 93 overseas countries. About 4,000 study papers have been reported throughout the world and i...